Publication | Closed Access

Intranasal Administration of HIV-DNA Vaccine Formulated with a Polymer, Carboxymethylcellulose, Augments Mucosal Antibody Production and Cell-Mediated Immune Response

VaccinationIntranasal AdministrationMucosal VaccinationVaccine DevelopmentHiv-dna Vaccine FormulatedCell-mediated Immune ResponseImmunologyTherapeutic VaccineVaccine DesignHivPolyvalent VaccineMedicine